Search

Financial results - JASMINE-PHARM SRL

0.00
Financial Summary - Jasmine-Pharm Srl
Unique identification code: 13736549
Registration number: J02/93/2001
Nace: 4773
Sales - Ron
174.098
Net Profit - Ron
1.844
Employees
3
Open Account
Company Jasmine-Pharm Srl with Fiscal Code 13736549 recorded a turnover of 2024 of 174.098, with a net profit of 1.844 and having an average number of employees of 3. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Jasmine-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 178.201 183.687 189.039 178.656 168.738 226.404 205.514 226.177 183.938 174.098
Total Income - EUR 178.711 183.688 189.040 178.658 168.739 226.601 205.515 230.366 183.942 174.486
Total Expenses - EUR 177.392 174.679 182.063 182.880 167.670 211.907 201.365 220.537 183.917 171.886
Gross Profit/Loss - EUR 1.319 9.010 6.978 -4.222 1.070 14.694 4.151 9.829 25 2.600
Net Profit/Loss - EUR 199 6.932 5.117 -6.030 -36 12.184 3.532 8.483 -137 1.844
Employees 4 3 4 4 4 4 3 4 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -4.8%, from 183.938 euro in the year 2023, to 174.098 euro in 2024. The Net Profit increased by 1.844 euro, from 0 euro in 2023, to 1.844 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Jasmine-Pharm Srl

Rating financiar

Financial Rating -
JASMINE-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Jasmine-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Jasmine-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Jasmine-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Jasmine-Pharm Srl - CUI 13736549

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 825 11.194 8.231 6.133 3.804 3.095 1.593 935 358 14.148
Current Assets 56.874 66.734 69.244 55.962 56.906 73.880 70.246 74.568 64.295 66.881
Inventories 51.881 59.259 59.314 49.444 49.331 58.274 53.787 49.101 45.064 53.975
Receivables 3.717 5.442 5.575 5.294 3.263 8.576 7.004 15.150 9.981 7.583
Cash 1.277 2.033 4.355 1.225 4.313 7.030 9.454 10.317 9.249 5.322
Shareholders Funds 775 7.699 5.871 -5.290 4.154 16.259 13.367 21.892 21.689 17.382
Social Capital 112 111 109 107 9.483 9.303 9.097 9.125 9.097 9.046
Debts 56.925 70.229 71.604 67.385 56.557 60.716 58.471 53.611 42.963 63.647
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 66.881 euro in 2024 which includes Inventories of 53.975 euro, Receivables of 7.583 euro and cash availability of 5.322 euro.
The company's Equity was valued at 17.382 euro, while total Liabilities amounted to 63.647 euro. Equity decreased by -4.187 euro, from 21.689 euro in 2023, to 17.382 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Jasmine-Pharm Srl

Comments - Jasmine-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.